Demographic characteristics: safety analysis set
| Characteristics | Total (N=15) |
| Sex, n (%) | |
| Male | 2 (13.3) |
| Female | 13 (86.7) |
| Race, n (%) | |
| White | 12 (80.0) |
| Black or African–American | 3 (20.0) |
| Age, years | |
| Median (range) | 57.0 (37–77) |
| ECOG performance status, n (%) | |
| 0 | 4 (26.7) |
| 1 | 11 (73.3) |
| Number of prior anticancer drug regimens*, n | |
| ≤2 | 1 |
| 3–5 | 9 |
| 6+ | 5 |
Eight of 15 patients had received radiotherapy and all patients had undergone anticancer surgery.
*Prior anticancer drug regimens include cytotoxic therapy, endocrine therapy, hormone therapy, or immunotherapy, or treatment with investigational agents, monoclonal antibodies, or small molecules.
ECOG, Eastern Cooperative Oncology Group.